## **Core Concept**
The question pertains to the selection of an appropriate inducing agent for anesthesia in a patient who is in shock. The primary goal in such scenarios is to choose an agent that maintains hemodynamic stability and does not further compromise the patient's blood pressure or cardiac output.

## **Why the Correct Answer is Right**
Etomidate (Option C) is often considered the inducing agent of choice in patients who are in shock because it has a minimal impact on cardiovascular function. It works by enhancing the effect of GABA (gamma-aminobutyric acid) at the GABA_A receptor, leading to sedation and hypnosis. Unlike other inducing agents, etomidate does not significantly depress myocardial contractility or cause vasodilation, making it particularly suitable for patients with compromised hemodynamics.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Propofol can cause significant hypotension and myocardial depression, making it less ideal for patients in shock.
- **Option B:** Thiopentone can also cause myocardial depression and decrease blood pressure, which could be detrimental in a patient who is already in shock.
- **Option D:** Ketamine can increase blood pressure and heart rate due to its sympathetic stimulating properties, but it may not be the best choice in certain types of shock (e.g., cardiogenic shock) and can increase myocardial oxygen demand.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that etomidate is often the preferred induction agent in hemodynamically unstable patients or those in shock because of its favorable cardiovascular profile. However, its use should be balanced with the potential for adrenal insufficiency with long-term use.

## **Correct Answer:** C. Etomidate.